Neurovascular Diseases and Biomarkers

Use of biomarkers in clinical practice is getting popular among physicians to aid making diagnostic and prognostic decisions. In certain areas of biomedicine, biomarker analysis has been incorporated to daily-practice as would be lipid-lowering therapy (LDL), the diagnosis of acute myocardial infarction (troponins), etc. Recently there has been a great interest for their use in neurovascular diseases to help physicians in various stages of the evaluation of stroke, from predicting the risk of suffering a stroke among healthy individuals to getting the biochemical diagnosis of stroke or using biomarkers as tools for outcome prediction.

This website attempts to provide a data compilation of published candidate biomarkers in the context of stroke (risk, diagnosis, subtype, etiology and prognosis), to offer updated protocols and to connect research groups with interest in the field.

Neurovascular Research Laboratory - Vall d'Hebron Research Institute (VHIR). 2020. Last update: 2018-02-02 14:48:58h.